Ankam, Inc.
A financially distressed OTC micro-cap with massive non-operating gains but deep accumulated losses and near-zero revenue.
A financially distressed OTC micro-cap with massive non-operating gains but deep accumulated losses and near-zero revenue.
An investor might consider this stock only if the massive non-operating income indicates a pending major asset sale or restructuring that will wipe out the accumulated deficits. The zero debt load and lack of long-term liabilities offer a clean slate for potential turnaround scenarios if new management acquires the shell at a nominal price. Any positive news regarding revenue generation could lead to disproportionate gains given the current negligible market capitalization.
The stock is fundamentally broken with a net loss, negative equity, and a complete lack of revenue over the last two years, making it an unsuitable investment for any risk-averse profile. The heavy reliance on non-operating income to cover expenses suggests there is no viable business model in place to generate sustainable profits from operations. With cash reserves nearly depleted and working capital changes turning negative, the likelihood of further dilution or delisting is extremely high.
Ankam, Inc. (ANKM) is a micro-cap entity trading on the OTC market with minimal recent revenue activity. The company reports significant non-operating income alongside substantial operating losses, indicating a primary focus on capital restructuring or strategic pivots rather than traditional product sales. With negligible current assets and a large retained earnings deficit, the firm operates in a high-risk environment typical of distressed shell companies.
Management appears to be utilizing non-operating gains to subsidize heavy operating expenses, resulting in a net loss of approximately $136K for the latest reporting period. Cash flow from operations is severely negative at -$157K, while financing activities provided a temporary cash injection of $157K, highlighting a reliance on external capital or debt restructuring rather than organic growth. The company has exhausted its cash reserves, dropping from $286 to just $57 in ending cash, signaling an urgent need for new funding or a viable revenue model.
This entity operates outside standard industry metrics due to its lack of revenue, effectively functioning as a special purpose acquisition vehicle or a distressed shell rather than a traditional operating company. The OTC market often hosts such low-capitalization firms that trade on the possibility of reverse mergers or asset flips rather than organic growth. Without defined products or markets served, the 'industry' is essentially the speculative micro-cap sector itself.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $1.8K | $27.2K | $104.5K |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $1.8K | $27.2K | $104.5K |
| Operating Expenses | $-53.5K | $-252.0K | $395.6K |
| Operating Income | $55.3K | $279.2K | $-291.2K |
| G&A | $26.6K | $390 | $63.1K |
| Other OpEx | $-259.7K | $-252.4K | $332.5K |
| Non-Operating Income | $0 | $0 | $154.3K |
| Pre-Tax Income | $55.3K | $279.2K | $-136.8K |
| Income Tax | $0 | $-18.9K | $0 |
| Continuing Ops | $55.3K | $298.0K | $-136.8K |
| Discontinued Ops | $-110.6K | $-577.2K | $0 |
| Net Income | $-55.3K | $-279.2K | $-136.8K |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-55.3K | $-279.2K | $-136.8K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $176.8K | $86.2K | $74.2K |
| Cash & Equivalents | — | $286 | — |
| Accounts Receivable | $4.8K | $21.4K | $0 |
| Other Current Assets | $172.0K | $64.5K | $74.2K |
| Long-Term Assets | $269.2K | $22.2K | $104.5K |
| Total Assets | $446.0K | $108.3K | $178.7K |
| Current Liabilities | $492.2K | $433.6K | $502.8K |
| Current Leases | — | — | $0 |
| Other Current Liab | — | — | $502.8K |
| Long-Term Liabilities | $0 | $0 | $0 |
| Total Liabilities | $492.2K | $433.6K | $502.8K |
| Shareholders' Equity | $46.1K | $-325.3K | $-324.1K |
| Paid-In Capital | $31.3K | $31.3K | $169.1K |
| Retained Earnings | $81.7K | $-360.9K | $-497.7K |
| Total L&E | $446.0K | $108.3K | $178.7K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-55.3K | $-279.2K | $-136.8K |
| Non-Cash Adjustments | $61.1K | $550.6K | $144.3K |
| Working Capital Changes | $129.0K | $48.9K | $-165.0K |
| Cash from Operations | $134.9K | $320.4K | $-157.5K |
| Cash from Investing | $-77.0K | $-241.4K | $0 |
| Cash from Financing | $213.3K | $77.0K | $157.3K |
| FX Effect | $-269.8K | $-154.0K | $0 |
| Net Change in Cash | $1.4K | $2.0K | $-229 |
| Beginning Cash | — | $2.3K | $286 |
| Ending Cash | — | $286 | $57 |
The financial profile suggests the company has no active core business segments generating revenue, relying instead on non-operating income streams such as asset sales or restructuring charges to offset operating expenses. The balance sheet indicates a lack of traditional product lines or service offerings, with all recorded assets classified as other current and long-term items rather than inventory or trade receivables.
The company faces an existential risk due to its negative shareholders' equity of over $324M and a retained earnings deficit exceeding half a million dollars. Investors must consider the risk of complete delisting or bankruptcy given the near-zero revenue trend and inability to generate positive cash flow from operations. The absence of accounts receivable and inventory suggests a lack of sustainable business operations, making the stock highly speculative.
The company's primary financial characteristic is the presence of significant non-operating income ($154M) which temporarily masks severe operational deficits. There are no traditional competitive moats given the lack of recurring revenue, but the firm maintains a clean long-term liability structure with zero debt obligations recorded on the balance sheet.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.